Oxytocin Effects on Cardiac Electrophysiology

Completed · Early Phase 1

Conditions studied: Cardiac Arrhythmia

In brief

In this pilot study the investigators will perform a double-blind randomized trial of intranasal oxytocin on measures of cardiac refractoriness, among individuals who are undergoing clinically indicated catheter ablation procedures for paroxysmal atrial fibrillation. The investigators seek to enroll 20 patients for this study, for the purpose of estimating effect sizes for a larger future study.

Key facts

Study ID

NCT01780337

Run by

William Whang

People needed

12

Starts

2013-01-01

Expected to finish

2016-05-01

Last updated by the study team

2016-07-21

Who can join

Age: 18 and older, up to 85. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Males and females older than 18 and younger than 85 years of age
• Undergoing catheter ablation for paroxysmal atrial fibrillation
• Presenting in sinus rhythm at the time of their procedure

You may not qualify if…

• Left ventricular ejection fraction <0.40
• Paced rhythm >50 percent of the time by device interrogation if a pacemaker is present

Where it is running

• Columbia University Medical Center — New York, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.